Blog archive

The dispute involved patent claims covering transgenic mice that were able to produce humanised antibodies.

As patent infringement litigation heads towards trial, patentees might expect that they will receive an interim injunction from the court in order to preserve the existing market position, at least temporarily.

The public consultation will last for three months (to 15 September 2020) and will focus on the following themes...

We've prepared a brief round-up of selected recent court rulings in the life sciences space.

We recently reviewed the law on cannabis-based medicines. It is clear that changes in scientific data and social attitudes mean that producers are faced with rapid evolution and differences in regulatory approach between countries, not only for medicines but for other products too. 

The UK Government’s efforts to bring the country out of lock-down in a safe way includes extensive guidance for different kinds of workplace.

James Fry considers practical, legal and regulatory issues for the sector arising from the current crisis, and what organisations can do to plan for the future...

EU legislation to introduce a new regulatory system for general medical devices (the Medical Devices Regulation) was to have taken effect from 26 May 2020.

The EU Commission has announced that it is working on a proposal to delay this date for one year in the light of the Coronavirus/COVID-19 crisis.

The government has announced a number of measures to support business during the coronavirus crisis including loan support in the form of CBILS and CCFF.

The UK Government is taking immediate action to support suppliers to the public sector where contract performance is affected due to COVID-19.

In these challenging times, many organisations are finding compliance with data protection law more difficult. Staff absences and homeworking, as well as the need to share health-related information, mean that normal policies and procedures are harder to follow.